Search
Patexia Research
Case number 1:18-cv-02107

Sumitomo Dainippon Pharma Co., Ltd. et al v. Par Pharmaceutical, Inc. > Documents

Date Field Doc. No.Description (Pages)
Apr 3, 2018 12 AO 120 Form Patent - Case Terminated - Submitted (3)
Docket Text: AO 120 FORM PATENT - CASE TERMINATED - SUBMITTED. In compliance with the provisions of 35 U.S.C. 290, the Director of the U.S. Patent and Trademark Office is hereby advised that a final decision was rendered on 04/02/2018 in a court action filed on the following patent(s) in the U.S. District Court Southern District of New York. Director of the U.S. Patent and Trademark Office electronically notified via Notice of Electronic Filing (NEF). (km)
Apr 2, 2018 11 Notice of Voluntary Dismissal (2)
Docket Text: NOTICE OF VOLUNTARY DISMISSAL Pursuant to Rule 41(a)(1)(A)(i) of the Federal Rules of Civil Procedure, the plaintiff(s) and or their counsel(s), hereby give notice that the above-captioned action is voluntarily dismissed, without prejudice against the defendant(s) Par Pharmaceutical, Inc.. Document filed by Sumitomo Dainippon Pharma Co., Ltd., Sunovion Pharmaceuticals Inc.. (Chacon, Megan)
Mar 14, 2018 10 Order for Initial Pretrial Conference (2)
Docket Text: ORDER AND NOTICE OF INITIAL CONFERENCE: It is hereby: ORDERED that counsel for all parties appear for an initial status conference on May 25, 2018 at 11:30 a.m. in Courtroom 1506 of the U.S. District Court for the Southern District of New York, 40 Foley Square, New York, New York. IT IS FURTHER ORDERED that, by May 18, 2018, the parties submit a joint letter, not to exceed five (5) pages, providing the following information in separate paragraphs as set forth in this order. IT IS FURTHER ORDERED that, by May 18, 2018, the parties jointly submit to the Court a proposed case management plan and scheduling order. A template for the standard order is available at http://nysd.uscourts.gov/judge/Abrams. The parties should adjust the standard proposed case management plan and scheduling order, however, to address the additional scheduling issues raised by the Local Patent Rules, which are available at page 97 of the Local Rules of the United States District Courts for the Southern and Eastern Districts of New York, http://nysd.uscourts.gov/rules/rules. pdf. The status letter and the proposed case management plan should be filed electronically on ECF, consistent with Section 13.1 of the Court's Electronic Case Filing (ECF) Rules & Instructions, available at http://www.nysd.uscourts.gov/ecf/ecf_rules_080113.pdf. Plaintiffs are ordered to serve Defendant with a copy of this order and to file an affidavit on ECF certifying that such service has been effectuated. SO ORDERED. Initial Conference set for 5/25/2018 at 11:30 AM in Courtroom 1506, 40 Foley Square, New York, NY 10007 before Judge Ronnie Abrams. (Signed by Judge Ronnie Abrams on 3/14/2018) (rj)
Mar 12, 2018 N/A Case Designated Patent Pilot Program (0)
Docket Text: Case Eligible for Patent Pilot Program. (pne)
Mar 12, 2018 N/A Notice to Attorney to Re-File Document - Deficient Docket Entry Error (0)
Docket Text:***NOTICE TO ATTORNEY TO RE-FILE DOCUMENT - DEFICIENT DOCKET ENTRY ERROR. Notice to Attorney Megan Alexandra Chacon to RE-FILE Document [2] Rule 7.1 Corporate Disclosure Statement,. ERROR(S): Corporate Parents were not added. Please re-file this document and when prompted: Are there any corporate parents or other affiliates?, select the YES radio button and enter the Corporate Parent(s) or Affiliate(s). YOU MUST SELECT THE SEARCH BUTTON. Select the correct name or create a new corporate parent. Add the Corporate Parent(s) or Affiliate(s) one party name at a time. (lb)
Mar 12, 2018 8 Mail Patent Form (case opening) (1)
Docket Text: AO 120 FORM PATENT - CASE OPENING - SUBMITTED. In compliance with the provisions of 35 U.S.C. 290, the Director of the U.S. Patent and Trademark Office is hereby advised that a court action has been filed on the following patent(s) in the U.S. District Court Southern District of New York. Director of the U.S. Patent and Trademark Office electronically notified via Notice of Electronic Filing (NEF). (pne)
Mar 12, 2018 9 Rule 7.1 Corporate Disclosure Statement (2)
Docket Text: RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Corporate Parent Sumitomo Dainippon Pharma Co., Ltd. for Sunovion Pharmaceuticals Inc.; Corporate Parent Sumitomo Chemical Co., Ltd. for Sumitomo Dainippon Pharma Co., Ltd.. Document filed by Sumitomo Dainippon Pharma Co., Ltd., Sunovion Pharmaceuticals Inc..(Chacon, Megan)
Mar 9, 2018 N/A Notice to Attorney Regarding Case Opening Statistical Error Correction (0)
Docket Text:***NOTICE TO ATTORNEY REGARDING CIVIL CASE OPENING STATISTICAL ERROR CORRECTION: Notice to attorney Megan Alexandra Chacon. The following case opening statistical information was erroneously selected/entered: County code XX Out of U.S. The following correction has been made to your case entry: the County code has been modified to XX Out of State. (pne)
Mar 9, 2018 N/A Notice to Attorney to Submit AO 120 Form/AO 121 Form (0)
Docket Text:***NOTICE TO ATTORNEY TO SUBMIT AO 120 FORM PATENT/TRADEMARK. Notice to Attorney Megan Alexandra Chacon to submit a completed AO 120 Form Patent/Trademark to court for review. Use the event type AO 120 Form Patent/Trademark - Notice of Submission by Attorney found under the event list Other Documents. (pne)
Mar 9, 2018 N/A Notice to Attorney Regarding Deficient AO 120/121 Form (0)
Docket Text:***NOTICE TO ATTORNEY REGARDING DEFICIENT PATENT FORM. Notice to Attorney Megan Alexandra Chacon to RE-FILE Document No. [5] Notice (Other). The filing is deficient for the following reason: the wrong event type was used to file the AO 120 Patent/Trademark form.. Re-file the document using the event type AO 120 Form Patent/Trademark - Notice of Submission by Attorney found under the event list Other Documents and attach the correct AO 120 Patent/Trademark PDF form. (pne)
Mar 9, 2018 N/A Case Opening Initial Assignment Notice (0)
Docket Text: CASE OPENING INITIAL ASSIGNMENT NOTICE: The above-entitled action is assigned to Judge Ronnie Abrams. Please download and review the Individual Practices of the assigned District Judge, located at http://nysd.uscourts.gov/judges/District. Attorneys are responsible for providing courtesy copies to judges where their Individual Practices require such. Please download and review the ECF Rules and Instructions, located at http://nysd.uscourts.gov/ecf_filing.php. (pne)
Mar 9, 2018 N/A Case Designation (0)
Docket Text: Magistrate Judge Stewart D. Aaron is so designated. Pursuant to 28 U.S.C. Section 636(c) and Fed. R. Civ. P. 73(b)(1) parties are notified that they may consent to proceed before a United States Magistrate Judge. Parties who wish to consent may access the necessary form at the following link: http://nysd.uscourts.gov/forms.php. (pne)
Mar 9, 2018 N/A Case Designated ECF (0)
Docket Text: Case Designated ECF. (pne)
Mar 9, 2018 6 AO 120 Form Patent/Trademark - Notice of Submission by Attorney (1)
Docket Text: AO 120 FORM PATENT - NOTICE OF SUBMISSION BY ATTORNEY. AO 120 Form Patent/Trademark for case opening submitted to court for review.(Chacon, Megan)
Mar 9, 2018 7 Summons Issued (2)
Docket Text: ELECTRONIC SUMMONS ISSUED as to Par Pharmaceutical, Inc. (pne)
Mar 8, 2018 1 Complaint (18)
Mar 8, 2018 1 Exhibit A - US Patent 9,815,827 (13)
Mar 8, 2018 2 Rule 7.1 Corporate Disclosure Statement (2)
Docket Text:FILING ERROR - CORPORATE PARENT/OTHER AFFILIATE NOT ADDED - RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by Sumitomo Dainippon Pharma Co., Ltd., Sunovion Pharmaceuticals Inc..(Chacon, Megan) Modified on 3/12/2018 (lb).
Mar 8, 2018 3 Request for Issuance of Summons (2)
Docket Text: REQUEST FOR ISSUANCE OF SUMMONS as to Par Pharmaceutical, Inc., re: [1] Complaint,. Document filed by Sumitomo Dainippon Pharma Co., Ltd., Sunovion Pharmaceuticals Inc.. (Chacon, Megan)
Mar 8, 2018 4 Civil Cover Sheet (2)
Docket Text: CIVIL COVER SHEET filed. (Chacon, Megan)
Mar 8, 2018 5 Notice (Other) (1)
Docket Text: FILING ERROR - WRONG EVENT TYPE SELECTED FROM MENU - NOTICE of Report on the Filing or Determination of an Action Regarding a Patent or Trademark re: [1] Complaint,. Document filed by Sumitomo Dainippon Pharma Co., Ltd., Sunovion Pharmaceuticals Inc.. (Chacon, Megan) Modified on 3/9/2018 (pne).
Mar 8, 2018 1 Main Document (18)
Docket Text: COMPLAINT against Par Pharmaceutical, Inc.. (Filing Fee $ 400.00, Receipt Number 0208-14787226)Document filed by Sumitomo Dainippon Pharma Co., Ltd., Sunovion Pharmaceuticals Inc.. (Attachments: # (1) Exhibit A - US Patent 9,815,827)(Chacon, Megan)
Mar 8, 2018 1 Complaint* (1)
Menu